The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu(Fujian Medical University), Dean G. Tang(Roswell Park Comprehensive Cancer Center), Randy Fagin, David T. Brown(Austin Community College), Hangwen Li(Shanghai East Hospital), Lubna Patrawala, Tammy Calhoun‐Davis(The University of Texas MD Anderson Cancer Center), Andreas G. Bader(Mirna Therapeutics (United States)), Bigang Liu(The University of Texas MD Anderson Cancer Center), Xin Chen(Liaoning University), Hong Yan(Nanjing Medical University), Sofia Honorio(The University of Texas MD Anderson Cancer Center), Jason F. Wiggins(Mirna Therapeutics (United States)), Kevin Kelnar(Mirna Therapeutics (United States)), Collene Jeter(The University of Texas MD Anderson Cancer Center)
Nature Medicine
January 16, 2011
Cited by 1,405


Related Papers